MOB — Moberg Pharma AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK434.29m
- SEK213.93m
- SEK13.54m
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains
Brief: Moberg Pharma Q1 EBITDA SEK -1.5 Million
Brief: Moberg Pharma, Karo Healthcare Expand Collaboration
Sweden's Moberg Pharma Q4 revenue rises
Brief: Moberg Pharma Q3 EBITDA SEK -5.6 Million
Brief: Moberg Pharma Enters Exclusive License Agreement With Karo Healthcare
Brief: Moberg Pharma Proposal To Withdraw Share Issue Authorization
Brief: Moberg Pharma Q2 Oper Loss At SEK 9.7 Mln
Brief: Moberg Pharma Q1 EBITDA Loss Narrows To SEK 3.7 Mln
Brief: Moberg Pharma Q4 EBITDA Loss Narrows To SEK 7.8 Mln
Brief: Moberg Pharma Reports Topline Data In The North American Phase 3 Study And Will Regain Rights To MOB-015 In EU
Brief: Moberg Pharma Lowers Expectations On Primary Endpoint In Ongoing Trial
Brief: Moberg Pharma Q2 EBITDA Loss Widens To SEK 5.2 Mln
Brief: Moberg Pharma Says Co Receives Sek 336 Mln Through To 2 & Directed Issue To Top Guarantors; Subscription Rate In To 2 Of 98%
Brief: Moberg Pharma Secures Exercise Of Warrants Of About SEK 113.5 Mln
Brief: Moberg Pharma Q1 EBITDA Loss Widens To SEK 7.6 Mln
Brief: Moberg Pharma Q4 EBITDA Loss Widens To SEK 8.0 Million
Brief: Moberg Pharma Q3 EBITDA Loss Widens To 6.6 Mln
Brief: Moberg Pharma Resolves Directed Issue Of Units To Guarantors In Connection With Completed Rights Issue